Jul 13,2020

Paige Secures Additional $15M from Goldman Sachs, for a Total Series B Funding Round of $70M

Paige, a global leader in computational pathology, today announced it received an additional $15M from Goldman Sachs Merchant Banking Division, totaling $20M from the firm. The funding will be added to previously announced Series B financing, bringing the total round to $70M, including an additional investment from Healthcare Venture Partners of $5M on top of their previous $10M investment. The funding brings the Company’s total capital raised to over $95M.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 28,2020

Nanox raises $59M for low-cost, downsized scanning tech to replace X-rays

Nanox is announcing another big step ahead in that plan: it has raised another $59 million in funding, closing out its Series B at $110 million, to continue building its full-body scanning hardware and securing more customers after already securing deals in 13 countries. The money is coming from a range of strategic investors that include SK Telecom, Industrial Alliance (the Canadian insurance group), Foxconn and Yozma Korea, and it has arrived swiftly on the heels of $51 million delivered in two tranches, the most recent being $20 million in June from strategic investor SK Telecom, which is building a factory to manufacture Nanox hardware in South Korea (there is another factory in Japan).

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 01,2019

Belong.Life raises $14 million to expand its digital cancer support network

Tel Aviv- and New York-based Belong.Life, a startup developing a digital support network for cancer patients that uses AI to create personalized experiences, today announced that it’s raised $14 million in series B funding led by Iqvia, with participation from The Group Ventures and other existing investors. The fresh funds bring the startup’s total raised to nearly $30 million following a $5 million series A in June 2015, and cofounder and CEO Eliran Malki says they’ll be used to expand Belong’s reach into new markets and diseases.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 18,2019

Paige raises $45M more to map the pathology of cancer using AI

One of the more notable startups using artificial intelligence to understand and fight cancer has raised $45 million more in funding to continue building out its operations and inch closer to commercialising its work. Paige — which applies AI-based methods such as machine learning to better map the pathology of cancer, an essential component of understanding the origins and progress of a disease with seemingly infinite mutations (its name is an acronym of Pathology AI Guidance Engine) — says it will be use the funding to inch closer to FDA approvals for products it is developing in areas such as biomarkers and prognostic capabilities.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Oct 21,2016

Oncology Care Planning Cloud-Based Software Company Carevive Systems Raises $7.2M in Series B Round

Carevive Systems, a leading innovator in cancer care planning software with a deep Real World Evidence-based dataset, announced today that it has closed on a $7.2 million Series B round of funding. Less than three years since the Company’s founding, the latest financial investment includes funding from Boston-based HLM Venture Partners and Long River Ventures.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jun 26,2019

DayTwo, Microbiome Startup for Diabetes, Raises $31M for U.S. Growth

DayTwo has snagged $31 million as it looks to provide nutritional support to the 30 million people living with type 2 diabetes across the United States.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 31,2019

Hello Heart collects $12M for digital chronic disease management

Hello Heart, maker of a digital chronic disease health program for employees, has raised $12 million in Series B funding. The round was led by Khosla Ventures, with additional support from previous backers BlueRun Ventures, Maven Ventures and Resolute Ventures. The company also branched out into diabetes management in 2018, adding blood sugar tracking tools alongside new personalized prompts designed to drive healthy behavior change

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Sep 17,2019

One Drop Launches Global Commercial Partnership with Bayer and Announces $40M in Series B Financing

One Drop, a leader in the development of digital therapeutic solutions for diabetes and other chronic conditions, today announced $40 million in Series B financing, led by Bayer, one of the largest pharmaceutical companies in the world. Bayer has also entered a commercial licensing agreement to use One Drop’s platform in Bayer’s global bio-digital efforts in therapeutic areas such as oncology, cardiovascular disease, and women’s health. Stefan Oelrich, the President of Bayer Pharmaceuticals, will join One Drop’s Board of Directors.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Nov 05,2019

Bayer Invests in UK Health Tech Firm Medopad

AI start-up Medopad, a crucial Health tech partner of Tencent has received $25m (£19.3m) as Series-B funding from German Pharmaceutical giant Bayer. Medopad's focus is on efforts to build digital biomarkers to diagnose diseases that are not detected easily by doctors or blood tests. The collected data from patients will be used by Medopad to analyze the progress of diseases. Alzheimer‘s and Diabetes are the other focus areas.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 02,2019

Diabeloop Completes Record-Breaking European Fundraising Effort With Its Autonomous Diabetes Management Solutions

Diabeloop announced today that it has completed a 31-million-euro Series B round of funding, setting a European fundraising record in the area of therapeutic artificial intelligence. This funding will allow Diabeloop to accelerate its international commercial deployment in both Europe and the US, and will support the award-winning company’s innovative programs.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES B